Age-related factors in child heart transplants

Progress in Pediatric Cardiology

Volumn 23, Issue 1-2, 2007, Pages 73-79

  Hsu, Daphne T ^a  

^a Columbia University ^*  (United States)

Author keywords

Children; Heart transplant; Outcomes

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PRAVASTATIN; PREDNISONE; RAPAMYCIN; TACROLIMUS;

AGE DISTRIBUTION; AGE SPECIFIC CARE; ARTICLE; ASSISTED VENTILATION; BEHAVIOR; CARDIOMYOPATHY; COGNITION; CORONARY ARTERY; DRUG EFFICACY; GRAFT RECIPIENT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMATURITY; IMMUNE SYSTEM; INCIDENCE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PEDIATRIC CARDIOLOGY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SURVIVAL; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 34547433606     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2007.05.011     Document Type: Article

References (46)

1. Lipshultz S.E., Sleeper L.A., Towbin J.A., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348 17 (2003) 1647-1655
2. Nugent A.W., Daubeney P.E., Chondros P., et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 348 17 (2003) 1639-1646
3. Boucek M.M., Waltz D.A., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric heart transplantation report-2006. J Heart Lung Transplant 25 8 (2006) 893-903
4. Towbin J.A., Lowe A.M., Colan S.D., et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296 15 (2006) 1867-1876
5. Morrow W.R., Naftel D., Chinnock R., et al. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group. J Heart Lung Transplant 16 12 (1997) 1255-1266
6. Bae J.O., Frischer J.S., Waich M., Addonizio L.J., Lazar E.L., and Stolar C.J. Extracorporeal membrane oxygenation in pediatric cardiac transplantation. J Pediatr Surg 40 6 (2005) 1051-1056 [discussion 1056-7]
7. Blume E.D., Naftel D.C., Bastardi H.J., Duncan B.W., Kirklin J.K., and Webber S.A. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation 113 19 (2006) 2313-2319
8. Levi D., Marelli D., Plunkett M., et al. Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. J Heart Lung Transplant 21 7 (2002) 760-770
9. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 20 (2001) 1435-1443
10. BarZiv S.M., McCrindle B.W., West L.J., et al. Outcomes of pediatric patients bridged to heart transplantation from extracorporeal membrane oxygenation support. ASAIO J 53 1 (2007) 97-102
11. Duncan B.W., Hraska V., Jonas R.A., et al. Mechanical circulatory support in children with cardiac disease. J Thorac Cardiovasc Surg 117 3 (1999) 529-542
12. Fiser W.P., Yetman A.T., Gunselman R.J., et al. Pediatric arteriovenous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation. J Heart Lung Transplant 22 7 (2003) 770-777
13. Hetzer R., Potapov E.V., Stiller B., et al. Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients. Ann Thorac Surg 82 3 (2006) 917-924 [discussion 924-5]
14. Baldwin J.T., Borovetz H.S., Duncan B.W., et al. The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program. Circulation 113 1 (2006) 147-155
15. Kearns G.L., Abdel-Rahman S.M., Alander S.W., Blowey D.L., Leeder J.S., and Kauffman R.E. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med 349 12 (2003) 1157-1167
16. del Mar Fernandez De Gatta M., Santos-Buelga D., Dominguez-Gil A., and Garcia M.J.. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations. Clin Pharmacokinet 41 2 (2002) 115-135
17. Kavukcu S., Soylu A., Turkmen M., Kasap B., Gumustekin M., and Gulay H. Two-hour post-dose cyclosporin A levels in adolescent renal transplant recipients in the late post-transplant period. Pediatr Nephrol 19 6 (2004) 667-671
18. Dipchand A.I., Pietra B., McCrindle B.W., Rosebrook-Bicknell H.L., and Boucek M.M. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil. J Heart Lung Transplant 20 10 (2001) 1035-1043
19. Schachter A.D., Benfield M.R., Wyatt R.J., et al. Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy. Pediatr Transplant 10 8 (2006) 914-919
20. Sindhi R. Sirolimus in pediatric transplant recipients. Transplant Proc 35 3 Suppl (2003) 113S-114S
21. Hedman M., Neuvonen P.J., Neuvonen M., Holmberg C., and Antikainen M. Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression. Clin Pharmacol Ther 75 1 (2004) 101-109
22. Wray J., Pot-Mees C., Zeitlin H., Radley-Smith R., and Yacoub M. Cognitive function and behavioural status in paediatric heart and heart-lung transplant recipients: the Harefield experience. BMJ 309 6958 (1994) 837-841
23. Wray J., and Radley-Smith R. Beyond the first year after pediatric heart or heart-lung transplantation: changes in cognitive function and behaviour. Pediatr Transplant 9 2 (2005) 170-177
24. Freier M.C., Babikian T., Pivonka J., et al. A longitudinal perspective on neurodevelopmental outcome after infant cardiac transplantation. J Heart Lung Transplant 23 7 (2004) 857-864
25. Brosig C., Hintermeyer M., Zlotocha J., Behrens D., and Mao J. An exploratory study of the cognitive, academic, and behavioral functioning of pediatric cardiothoracic transplant recipients. Prog Transplant 16 1 (2006) 38-45
26. Todaro J.F., Fennell E.B., Sears S.F., Rodrigue J.R., and Roche A.K. Review: cognitive and psychological outcomes in pediatric heart transplantation. J Pediatr Psychol 25 8 (2000) 567-576
27. Uzark K.C., Sauer S.N., Lawrence K.S., Miller J., Addonizio L., and Crowley D.C. The psychosocial impact of pediatric heart transplantation. J Heart Lung Transplant 11 6 (1992) 1160-1167
28. Wray J., and Radley-Smith R. Longitudinal assessment of psychological functioning in children after heart or heart-lung transplantation. J Heart Lung Transplant 25 3 (2006) 345-352
29. Mintzer L.L., Stuber M.L., Seacord D., Castaneda M., Mesrkhani V., and Glover D. Traumatic stress symptoms in adolescent organ transplant recipients. Pediatrics 115 6 (2005) 1640-1644
30. Wray J., and Radley-Smith R. Depression in pediatric patients before and 1 year after heart or heart-lung transplantation. J Heart Lung Transplant 23 9 (2004) 1103-1110
31. Rianthavorn P., Ettenger R., Malekzadeh M., Marik J., and Struber M. Noncompliance with immunosuppressive medications in pediatric and adolescent patients receiving solid-organ transplants. Transplantation 15 5 (2004) 778-782
32. Sigfusson G., Fricker F., Bernstein D., et al. Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr 130 6 (1997) 862-871
33. Dew M., Roth L., Thompson M., Kormos R., and Griffith B. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant 15 6 (1996) 631-645
34. Sredl D., Werner T., Springhart D., Watkins D., Shaner M., and McBride G. An evidence-based pilot study exploring relationships between psychologic and physiologic factors in post-lung transplant adolescents with cystic fibrosis. J Pediatr Nurs 18 3 (2003) 216-220
35. Nevins T.E. Non-compliance and its management in teenagers. Pediatr Transplant 6 6 (2002) 475-479
36. Shemesh E., Lurie S., Stuber M., et al. A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics 105 2 (2000) E29
37. Shemesh E., Shneider B.L., Savitzky J.K., et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 113 4 (2004) 825-832
38. Beck D., Fennell R., Yost R., Robinson J., Geary D., and Richards G. Evaluation of an educational program on compliance with medication regimens in pediatric patients with renal transplants. J Pediatr 96 6 (1980) 1094-1097
39. Shaw R.J., Palmer L., Blasey C., and Sarwal M. A typology of non-adherence in pediatric renal transplant recipients. Pediatr Transplant 7 6 (2003) 489-493
40. Falkenstein K., Flynn L., Kirkpatrick B., Casa-Melley A., and Dunn S. Non-compliance in children post-liver transplant. Who are the culprits?. Pediatr Transplant 8 3 (2004) 233-236
41. Ringewald J., Gidding S., Crawford S., Backer C., Mavroudis C., and Pahl E. Nonadherence is associated with late rejection in pediatric heart transplant recipients. J Pediatr 139 1 (2001) 75-80
42. Meyers K., Thomson P., and Weiland H. Noncompliance in children and adolescents after renal transplantation. Transplantation 62 2 (1996) 186-189
43. Meyers K., Weiland H., and Thomson P. Paediatric renal transplantation non-compliance. Pediatr Nephrol 9 2 (1995) 189-192
44. Wolff G., Strecker K., Vester U., Latta K., and Ehrich J. Non-compliance following renal transplantation in children and adolescents. Pediatr Nephrol 12 9 (1998) 703-708
45. Blowey D., Hebert D., Arbus G., Pool R., Korus M., and Koren G. Compliance with cyclosporine in adolescent renal transplant recipients. Pediatr Nephrol 11 5 (1997) 547-551
46. Watson A.R. Non-compliance and transfer from pediatric to adult transplant unit. Pediatr Nephrol 14 6 (2000) 469-472